Article info

Download PDFPDF

SAT0198 Tocilizumab for the management of rheumatoid arthritis: discontinuation due to inefficacy and toxicity – experience from a large teaching hospital
Free

Authors

Citation

Byrne E, Mark P, Khalid S, et al
SAT0198 Tocilizumab for the management of rheumatoid arthritis: discontinuation due to inefficacy and toxicity – experience from a large teaching hospital

Publication history

  • First published June 15, 2017.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.